TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 52 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,190,057 | +11.2% | 2,880,701 | +13.1% | 1.08% | +23.1% |
| Q2 2023 | $46,044,619 | +43.8% | 2,548,125 | 0.0% | 0.88% | +31.5% |
| Q1 2023 | $32,029,931 | -14.3% | 2,548,125 | 0.0% | 0.67% | -12.6% |
| Q4 2022 | $37,355,513 | +7.8% | 2,548,125 | +25.9% | 0.76% | -4.5% |
| Q3 2022 | $34,637,000 | +17.8% | 2,023,179 | +0.5% | 0.80% | +5.1% |
| Q2 2022 | $29,399,000 | -13.2% | 2,013,601 | 0.0% | 0.76% | +8.4% |
| Q1 2022 | $33,869,000 | -25.2% | 2,013,601 | 0.0% | 0.70% | +5.9% |
| Q4 2021 | $45,306,000 | +4.4% | 2,013,601 | 0.0% | 0.66% | +1.2% |
| Q3 2021 | $43,393,000 | -25.6% | 2,013,601 | 0.0% | 0.65% | -25.8% |
| Q2 2021 | $58,354,000 | -26.2% | 2,013,601 | -18.3% | 0.88% | -28.7% |
| Q1 2021 | $79,091,000 | -20.1% | 2,463,601 | 0.0% | 1.24% | -25.6% |
| Q4 2020 | $98,987,000 | – | 2,463,601 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
| Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
| Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
| Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
| RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
| COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
| Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
| Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
| TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
| Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |